Common dermatologic infections in athletes and return-to-play guidelines

Journal of the American Osteopathic Association

Volumn 111, Issue 6, 2011, Pages 373-379

  Likness, Lincoln P ^a  

^a Western Wisconsin Medical Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; CONSUMER; DISEASE TRANSMISSION; HEALTH STATUS; HUMAN; MYCOSIS; REVIEW; SKIN DISEASE; SPORT; SPORTS MEDICINE; UNITED STATES; VIRUS INFECTION;

BACTERIAL INFECTIONS; CONSUMER PARTICIPATION; HEALTH STATUS; HUMANS; MYCOSES; SKIN DISEASES; SPORTS; SPORTS MEDICINE; UNITED STATES; VIRUS DISEASES;

EID: 79960695076     PISSN: 00986151     EISSN: 19451997     Source Type: Journal    
DOI: 10.7556/jaoa.2011.111.6.373     Document Type: Article

References (33)

1. Guideline 2j: Skin infections in athletics. In: National Collegiate Athletic Association Sports Medicine Handbook. 19th ed. Indianapolis, IN: National Collegiate Athletic Association; 2008:52-59.
2. Yard EE, Collins CL, Dick RW, Comstock RD. An epidemiologic comparison of high school and college wrestling injuries [published online ahead of print October 11, 2007]. Am J Sports Med. 2008;36(1):57-64.
3. Adams BB. Skin infections in athletes [review]. Dermatol Nurs. 2008;20(1): 39-44.
4. Adams BB. Sports dermatology [review]. Adolesc Med. 2001;12(2):305-322.
5. Anderson BJ. The epidemiology and clinical analysis of several outbreaks of herpes gladiatorum. Med Sci Sports Exerc. 2003;35(11):1809-1814.
6. Anderson BJ. Managing herpes gladiatorum outbreaks in competitive wrestling: The 2007 Minnesota experience. Curr Sports Med Rep. 2008;7(6):323-327.
7. Anderson BJ. Skin infections in Minnesota high school state tournament wrestlers: 1997-2006. Clin J Sport Med. 2007;17(6):478-480.
8. Agel J, Ransone J, Dick R, Oppliger R, Marshall SW. Descriptive epidemiology of collegiate men's wrestling injuries: National Collegiate Athletic Association Injury Surveillance System, 1988-1989 through 2003-2004. J Athl Train. 2007;42(2):303-310.
9. Robins CM, Elewski BE. Tinea pedis. Medscape Reference Web site. Updated December 16, 2009. http://emedicine.medscape.com/article/1091684-overview. Accessed May 23, 2011.
10. Pleacher MD, Dexter WW. Cutaneous fungal and viral infections in athletes. Clin Sports Med. 2007;26(3):397-411.
11. Fitzpatrick TB, Johnson RA, Wolff K, Suurmond D. Fitzpatrick's Color Atlas & Synopsis of Clinical Dermatology. 3rd ed. New York, NY: McGraw-Hill; 1997.
12. Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 4th ed. St Louis, MO: Mosby; 2004.
13. National Federation of State High School Associations, Sports Medicine Advisory Committee. Sports Related Skin Infections Position Statement and Guidelines. Indianapolis, IN: National Federation of State High School Associations; April 2010. http://www.nfhs.org/content.aspx?id=3325. Accessed May 15, 2011.
14. Gupta AK, Cooper EA, Ryder JE, Nicol KA, Chow M, Chaudhry MM. Optimal management of fungal infections of the skin, hair, and nails. Am J Clin Dermatol. 2004;5(4):225-237.
15. Winokur RC, Dexter WW. Fungal infections and parasitic infections in sports: Expedient identification and treatment. Phys Sportsmed. 2004; 32(10):23-33.
16. Kohl TD, Martin DC, Nemeth R, Hill T, Evans D. Fluconazole for the prevention and treatment of tinea gladiatorum. Pediatr Infect Dis J. 2000; 19(8):717-722.
17. Pickup TL, Adams BB. Prevalence of tinea pedis in professional and college soccer players versus non-athletes. Clin J Sport Med. 2007;17(1):52-54.
18. Budimulja U, Bramono K, Urip KS, et al. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study. Mycoses. 2001;44 (7-8):300-306.
19. Sharp JCM. ABC of sports medicine. Infections in sport. BMJ. 1994;308 (6945):1702-1796.
20. Lautenbach E, Zaoutis T. Preventing MRSA infection in the community. LDI Issue Brief. 2009;14(6):1-4.
21. Gupta K, MacIntyre A, Vanasse G, Dembry LM. Trends in prescribing β-lactam antibiotics for treatment of community-associated methicillin-resistant Staphylococcus aureus infections [published online ahead of print October 17, 2007]. J Clin Microbiol. 2007;45(12):3930-3934.
22. Bowers AL, Huffman GR, Sennett BJ. Methicillin-resistant Staphylococcus aureus infections in collegiate football players. Med Sci Sports Exerc. 2008;40(8):1362-1367.
23. Safdar N, Bradley EA. The risk of infection after nasal colonization with Staphylococcus aureus [review]. Am J Med. 2008;121(4):310-315.
24. Simor AE, Phillips E, McGeer A, et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin resistant Staphylococcus aureus colonization [published online ahead of print December 14, 2006]. Clin Infect Dis. 2007;44(2):178-185.
25. Loeb M, Main C, Walker-Dilks C, Eady A. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev. 2003;(4):CD003340.
26. Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-sight infections in nasal carriers of Staphylococcus aureus. N Engl J Med. 2010;362(1):9-17.
27. Rihn JA, Posfay-Barbe K, Harner CD, et al. Community-acquired methacillinresistant Staphylococcus aureus outbreak in a local high school football team unsuccessful interventions. Pediatr Infect Dis J. 2005;24(9):841-843.
28. Cohen PR. The skin in the gym: A comprehensive review of the cutaneous manifestations of community-acquired methicillin-resistant Staphylococcus aureus infection in athletes. Clin Dermatol. 2008;26(1):16-26.
29. Yang LP, Keam SJ. Retapamulin: A review of its use in the management of impetigo and other uncomplicated superficial skin infections. Drugs. 2008;68(6):855-873.
30. Yang LP, Keam SJ. Spotlight on retapamulin in impetigo and other uncomplicated superficial skin infections. Am J Clin Dermatol. 2008;9(6):411-413.
31. Koning S, van der Wouden JC, Chosidow O, et al. Efficacy and safety of retapamulin ointment as treatment of impetigo: Randomized double-blind multicentre placebo-controlled trial [published online ahead of print March 13, 2008]. Br J Dermatol. 2008;158(5):1077-1082.
32. Parish LC, Parish JL. Retapamulin: A new topical antibiotic for the treatment of uncomplicated skin infections. Drugs Today. 2008;44(2):91-102.
33. Stevens DL, Bisno AL, Chambers, et al; Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft-tissue infections [published online ahead of print October 14, 2005]. Clin Infect Dis. 2005;41(10):1373-1406.